Pyoderma gangrenosum complicating ulcerative colitis: Successful treatment with methylprednisolone pulse therapy and cyclosporine

Journal of Gastroenterology

Volumn 33, Issue 3, 1998, Pages 408-411

  Futami, Hajime ^a   Kodaira, Makoto ^a   Furuta, Takahisa ^a   Hanai, Hiroyuki ^a   Kaneko, Eizo ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cyclosporine; Pyoderma gangrenosum; Ulcerative colitis

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PUERPERIUM; PYODERMA GANGRENOSUM; RELAPSE; REMISSION; ULCERATIVE COLITIS;

ADULT; ANTI-INFLAMMATORY AGENTS; COLITIS, ULCERATIVE; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FACIAL DERMATOSES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; METHYLPREDNISOLONE; PREGNANCY; PREGNANCY COMPLICATIONS; PYODERMA GANGRENOSUM;

EID: 0031799222     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350050104     Document Type: Article

References (26)

1. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: A study of 700 patients. Medicine 1976;5:401-412.
2. Mir-Madjlessi SH, Taylor JS, Farmer RG. Clinical course and evolution of erythema nodosum and pyoderma gangrenosum in chronic ulcerative colitis: A study of 42 patients. Am J Gastroenterol 1985;80:615-620.
3. Johnson RD, Lazarus GS. Pulse therapy: Therapeutic efficacy in the treatment of pyoderma gangrenosum. Arch Dermatol 1982;118:76-84.
4. Prystowsky JH, Kahn SN, Lazarus GS. Present state of pyoderma gangrenosum: Review of 21 cases. Arch Dermatol 1989;125:57-64.
5. Curley RK, Macfarlane AW, Vickers CF. Pyoderma gangrenosum treated with cyclosporin A. Br J Dermatol 1985; 113:601-604.
6. Elgart G, Stover P, Larson K, et al. Treatment of pyoderma gangrenosum with cyclosporine: Results in seven patients. J Am Acad Dermatol 1991;23:83-86.
7. Lichtger S, Present DH. Preliminary report: Cyclosporin in treatment of severe active ulcerative colitis. Lancet 1990;336:16-19.
8. Lichtiger S, Present DH, Korrnbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994;330:1841-1845.
9. Hickman JG, Lazarus GS. Pyoderma gangrenosum: A reappraisal of associated systemic disease. Br J Dermatol 1980;102:235-237.
10. Stolman LP, Rosenthal D, Yaworsky R, et al. Pyoderma gangrenosum and rheumatoid arthritis. Arch Dermatol 1975; 111:1020-1023.
11. Lewis SJ, Fine JD, Schaffer EH, et al. Atypical pyoderma gangrenosum with leukemia. JAMA 1973;39:935-938.
12. Sampson JA, Harris OD, van Deth AG. Pyoderma gangrenosum and chronic active hepatitis. Aust J Dermatol 1982;23:93-96.
13. Maturi MF, Fine JD, Schaffer EH, et al. Pyoderma gangrenosum associated with primary biliary cirrhosis. Arch Intern Med 1983;143:1261-1263.
14. Willoughby CP, Truelove SC. Ulcerative colitis and pregnancy. Gut 1980;21:469-474.
15. Nielsen OH, Andreasson B, Bondeson S, et al. Pregnancy in ulcerative colitis. Scand J Gastroenterol 1983;18:735-742.
16. de Dombal FT, Watts JM, Watkinson G, et al. Ulcerative colitis and pregnancy. Lancet 1965;II:599-601.
17. Ralph B, Mark H, Adam L, et al. Fulminant ulcerative colitis in pregnancy. Am J Gastroenterol 1994;89:931-933.
18. Nicholas NS, Panayi GS, Nouri AM. Human pregnancy serum inhibits interleukin-2 production. Clin Exp Immunol 1984;58:587-595.
19. Garcia Domingo C, Moreno A, Palomino P. The effect of human pregnancy serum on the synthesis and action of interleukin-1. J Reproduct Immunol 1988;13:17-30.
20. Bendtzen K. Immune hormones (cytokines); pathogenic role in autoimmune rheumatic and endocrine disease. Autoimmunity 1989;92:177-189.
21. Brynskov J. Cyclosporin for inflammatory bowel disease: Mechanisms and possible actions. Scand J Gastroenterol 1993;28:849-857.
22. Galun E, Flugelman MY, Rachmilewitz D. Pyoderma gangrenosum complicating ulcerative colitis: Successful treatment with methylprednisolone pulse therapy and dapsone. Am J Gastroenterol 1986;10:988-989.
23. Curley RK, Macfarlane AW, Vickers CF. Pyoderma gangrenosum treated with cyclosporin A. Br J Dermatol 1985; 113:601-604.
24. Elgart G, Stover P, Larson K, et al. Treatment of pyoderma gangrenosum with cyclosporine: Results in seven patients. J Am Acad Dermatol 1991;23:83-86.
25. Öst L. Impairment of prednisolone metabolism by cyclosporine treatment in renal graft recipients. Transplantation 1987;44:533-535.
26. Atkinson K, Britton K, Paull P, et al. Detrimental effect of intestinal disease on absorption of orally administered cyclosporine. Transplant Proc 1983;15:2446-2449.